STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

DNA VACCINE AGAINST LEISHMANIASIS

USE OF TRIMANGANESE TETRAOXIDE PARTICLES IN PREPARATION OF VACCINE ADJUVANT

ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS

Vaccine Compositions for Trypanosomatids

THERAPEUTIC VACCINE COMPRISING A SPECIFIC ANTIGEN OF A DISEASE THAT DOES NOT AFFECT THE CENTRAL NERVOUS SYSTEM AND NANOPARTICLES, AND USE OF THE VACCINE

LIVE ATTENUATED LEISHMANIA PARASITE VACCINES WITH ENHANCED SAFETY CHARACTERISTICS

USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT

Chimeric protein, method of production and use thereof, and also a nucleic acid molecule, expression cassette, expression vector, host cell, composition for the diagnosis of leishmaniasis, kit for the diagnosis of leishmaniasis and method of diagnosis of leishmaniasis in vitro

PEPTIDE IMMUNOGENS TARGETING INTERLEUKIN 6 (IL-6) AND FORMULATIONS THEREOF FOR IMMUNOTHERAPY OF DISEASES IMPACTED BY IL-6 DYSREGULATION

Anti-parasitic immunological compositions

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

Multi-epitopic peptide compounds and vaccines against leishmaniasis

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

METHODS OF USING A VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Immunotherapy of leishmaniasis

Method of inducing an immune response using an expression construct and GLA

IMMUNOTHERAPY OF SOLID TUMORS BY VACCINATION WITH TRANSGENIC LEISHMANIA EXPRESSING CANCER VACCINES AND WITH RECOMBINANT VACCINES WITH LEISHMANIA AS ADJUVANTS

Molecular adjuvant and vaccine

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS

Vaccines Against Leishmania Infection

STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS

Immunotherapy of canine leishmaniasis

Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of leishmania infantum with specific immunodominant epitopes

Regulatory T cell PD-1 modulation for regulating T cell effector immune responses

Molecular adjuvant and vaccine

Methods of using a vaccine composition containing synthetic adjuvant

Vaccine composition containing synthetic adjuvant

Vaccine Composition Containing Synthetic Adjuvant

polypeptides and methods of use

Glycoconjugate vaccine for

SYNERGISTIC COMPOSITIONS OF IMMUNOSTIMULATING RECONSTITUTED INFLUENZA VIROSOMES WITH IMMUNOPOTENTIATORS AND VACCINES CONTAINING THEM

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure

polypeptides and methods of use

Vaccines comprising polypeptides for the treatment and diagnosis of leishmaniasis

VACCINES COMPRISING LEISHMANIA POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Vaccine composition containing synthetic adjuvant

Means for Eliciting an Immune Response and a Method Transfer

polypeptides and methods of use

Hemoglobin receptor as novel vaccine for leishmaniasis

AMINO ACID SEQUENCES FOR CLINICAL REMISSION OF PSORIASIS AND RELATED DISEASES.

Methods of using a vaccine composition containing synthetic adjuvant

Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the PFR1 protein of leishmania infantum with specific immunodominant epitopes

Vaccine composition and immunization method

Molecule for treating an inflammatory disorder

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

NOVEL AGENTS FOR THE PREVENTION OF LEISHMANIASIS

Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure

Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins

Vaccine composition containing synthetic adjuvant

Controlled release formulation based on hematin anhydride crystals for the induction of an innate immune reaction

LEISHMANIASIS ANTIGEN DETECTION ASSAYS AND VACCINES

Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom

Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis

Methods of using a vaccine composition containing synthetic adjuvant

ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM

Leishmania-based carrier for vaccine delivery

Transcutaneous immunization without heterologous adjuvant

Process and composition for treatment of canine and human leishmaniasis

VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

Treatment of allergic conditions using a composition containing synthetic adjuvant

Olioodeoxynucleotide and its use to induce an immune response

DNA expression constructs encoding the antigens thiol-specific antioxidant protein and kinetoplastid membrane protein

Oligodeoxynucleotide and its use to induce an immune response

CYCLIZED NON-NATIVE SYNTHETIC PEPTIDE AND COMPLEX OF PEPTIDES COMPRISING SAID CYCLIZED PEPTIDE, INTENDED TO INDUCE AND TO CHARACTERIZE THE PREVENTION OR TREATMENT OF CONDITIONS IN MAMMALS

Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis

Live attenuated vaccines

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

VACCINE COMPRISING A RIBOSOMAL PROTEIN EXTRACT (RPE) AND OPTIONALLY A TH1-PROMOTING ADJUVANT

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Vaccine composition and immunization method

Vaccination with killed but metabolically active (KBMA) protozoans with toll-like receptor agonists

Canine leishmania vaccine

P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE

Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis

Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis

Composition comprising the N-terminal region of histone H2B of leishmania—use thereof for inducing an immune response

SYNTHETIC MONODISPERSE HEMOZOIN CRYSTALS PREPARATION AND USES THEREOF

Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis

Means for obtaining avirulent promastigotes, promastigotes obtained, and the applications thereof

Composition comprising fractions or sub-fraction of leishmania promastigotes or leishmania amastigotes called fucose mannose ligand (fml) and saponin, composition for preparation of leishmaniasis transmission blocking vaccines in humans and animals comprising fractions or sub-fractions of leishmania promastigotes or leis

VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT

Lutzomyia longipalpis polypeptides and methods of use

Dry Formulation for Transcutaneous Immunization

sterol 24-c-methyltransferase compositions for the prevention, treatment and diagnosis of leishmaniasis

VACCINE FORMULATIONS FOR LEISHMANIA

Canine vaccine

Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF LEISHMANIASIS

DNA vaccine as immunoprophylaxis against Kala-azar

Vaccine composition containing synthetic adjuvant

Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant

Agents for the prevention of

Oligodeoxynucleotide and its use to induce an immune response

Live attenuated vaccines

Method for generating antigen-presenting cells

Agent for treating leishmania infections

Method of obatining cochlear structures, vaccine compositions, adjuvants and interme- diates thereof

Vaccine complex for preventing or treating leishmaniases

polypeptides and methods of use

Suicidal mutant vaccine

polypeptides, polypeptides and methods of use

Transcutaneous immunization without heterologous adjuvant

Chimeric gene formed of the DNA sequences that encode the antigenic determinants of four proteins of L. infantum, useful for serologic diagnosis of canine leishmaniosis and protein obtained

Oligodeoxynucleotide and its use to induce an immune response

Vaccine to protect animals against leishmania